Continued loss in visceral and intermuscular adipose tissue in weight‐stable women following bariatric surgery

Objective To assess changes in total (TAT), subcutaneous (SAT), visceral (VAT), and intermuscular (IMAT) adipose tissue by whole‐body MRI before surgery and at 12 months and 24 months post‐surgery in a subset of participants of the Longitudinal Assessment of Bariatric Surgery‐2. Methods From 0 to 12...

Full description

Saved in:
Bibliographic Details
Published inObesity (Silver Spring, Md.) Vol. 23; no. 1; pp. 62 - 69
Main Authors Toro‐Ramos, Tatiana, Goodpaster, Bret H., Janumala, Isaiah, Lin, Susan, Strain, Gladys W., Thornton, John C., Kang, Patrick, Courcoulas, Anita P., Pomp, Alfons, Gallagher, Dympna
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.01.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective To assess changes in total (TAT), subcutaneous (SAT), visceral (VAT), and intermuscular (IMAT) adipose tissue by whole‐body MRI before surgery and at 12 months and 24 months post‐surgery in a subset of participants of the Longitudinal Assessment of Bariatric Surgery‐2. Methods From 0 to 12 months, n = 20 females and 3 males; from 12 to 24 months, n = 42 females and 7 males. Paired t‐tests and GLM repeated measures examined changes in TAT, SAT, VAT, and IMAT at 12 and 24 months, with sex and age as covariates. Results Changes from 0 to 12 months included weight (−41.9 ± 12.1 kg; −36%), TAT (−33.5 ± 9.6 kg; −56%), SAT (−29.2 ± 8.2 kg; −55%), VAT (−3.3 ± 1.6 kg; −73%), and IMAT (−0.99 ± 0.68 kg; −50%), all P < 0.001. In females, from 12 to 24 months, despite relative weight stability (−1.8 ± 6.5 kg, −2%; P = 0.085), VAT (−0.5 ± 0.7 kg; −30%; P < 0.001) and IMAT (−0.2 ± 0.4 kg; −14%; P = 0.012) decreased further. In males, from 12 to 24 months, weight increased (5.1 ± 5.2 kg; 6%; P = 0.04) with no significant changes in TAT or sub‐depots. Conclusions Bariatric surgery continues to induce favorable changes in body composition, i.e., persistent adipose tissue loss at 24 months in the absence of further significant weight loss.
Bibliography:Supported by National Institutes of Health grants RO1‐DK‐72507, P30‐DK‐26687, UL1 TR000040. T. Toro‐Ramos supported by a diversity supplement UO1DK094463.
Disclosure
Funding agencies
Dr. Gallagher reports grants from National Institutes of Health during the conduct of the study; Dr. Courcoulas reports grants from NIH/NIDDK during the conduct of the study and grants from Nutrisystem, grants from EndoGastric Solutions, grants from Covidien, and personal fees from J&J Ethicon Scientific outside the submitted work.
Author contributions
DG designed the study. IJ analyzed all MRI scans. GS, WY, SL, BG, JT, AC, AP contributed to recruitment, study procedures, and database management. TT‐R, SL, and JT conducted the analyses. TT‐R and DG wrote the paper. All authors were involved in writing the paper and had final approval of the submitted and published versions.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current affiliation: Translational Research Institute for Metabolism and Diabetes, Orlando, Florida
ISSN:1930-7381
1930-739X
DOI:10.1002/oby.20932